Nintedanib Reduces Neutrophil Chemotaxis via Activating GRK2 in Bleomycin-Induced Pulmonary Fibrosis

被引:26
作者
Chen, Wei-Chih [1 ,2 ,3 ]
Chen, Nien-Jung [4 ,5 ]
Chen, Hsin-Pai [2 ,6 ]
Yu, Wen-Kuang [1 ,2 ,7 ]
Su, Vincent Yi-Fong [2 ,8 ]
Chen, Hao [1 ]
Wu, Huai-Hsuan [1 ]
Yang, Kuang-Yao [1 ,2 ,3 ,5 ]
机构
[1] Taipei Vet Gen Hosp, Dept Chest Med, Taipei 112, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan
[3] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Sch Med, Taipei 112, Taiwan
[4] Natl Yang Ming Univ, Inst Microbiol & Immunol, Sch Life Sci, Taipei 112, Taiwan
[5] Natl Yang Ming Univ, Canc Progress Res Ctr, Taipei 112, Taiwan
[6] Taipei Vet Gen Hosp, Div Infect Dis, Dept Med, Taipei 112, Taiwan
[7] Natl Yang Ming Univ, Inst Physiol, Sch Med, Taipei 112, Taiwan
[8] Taipei City Hosp, Dept Internal Med, Taipei 112, Taiwan
关键词
nintedanib; neutrophil; chemokine (C-X-C motif) receptor 2 (CXCR2); G protein-coupled receptor kinase 2 (GRK2); pulmonary fibrosis; VASCULAR ENDOTHELIAL-CELLS; ACUTE LUNG INJURY; ADHESION; INHIBITOR; EXPRESSION; MODELS; PATHOGENESIS; INFLAMMATION; MIGRATION; DIAGNOSIS;
D O I
10.3390/ijms21134735
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neutrophils are involved in the alveolitis of idiopathic pulmonary fibrosis (IPF). However, their pathogenic mechanisms are still poorly understood. Nintedanib has antifibrotic and anti-inflammatory activity in IPF. This study aimed to investigate the regulatory mechanism of nintedanib on neutrophil chemotaxis in bleomycin (BLM)-induced pulmonary fibrosis. Nintedanib was administered via oral gavage to male C57BL/6 mice 24 h after a bleomycin intratracheal injection (1.5 U/kg). Lung histopathological findings, the expression of cytokines, and the regulatory signaling pathways of neutrophil chemotaxis were analyzed. The effect of nintedanib was also investigated in a mouse model with adoptive neutrophil transfer in vivo. Nintedanib significantly decreased the histopathological changes and neutrophil recruitment in BLM-induced pulmonary fibrosis. Nintedanib mediated a downregulation of chemokine (C-X-C motif) receptor 2 (CXCR2) and very late antigen 4 (VLA-4) expression, as well as an upregulation of G protein-coupled receptor kinase 2 (GRK2) activity in peripheral blood neutrophils in BLM-induced pulmonary fibrosis. Nintedanib also decreased the activation of endothelial cells by the decreased expression of vascular cell adhesion molecule 1 (VCAM-1). The effect of nintedanib on regulating neutrophil chemotaxis was also confirmed by a mouse model with adoptive neutrophil transfer in vivo. In conclusion, nintedanib reduces neutrophil chemotaxis and endothelial cell activation to regulate the severity of BLM-induced pulmonary fibrosis. These effects are associated with an enhancement of GRK2 activity and a reduction in CXCR2 and VLA-4 expression on neutrophils and a decrease in VCAM-1 expression on endothelial cells.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 50 条
  • [1] Paroxetine protects against bleomycin-induced pulmonary fibrosis by blocking GRK2/Smad3 pathway
    Zhao, Kaochang
    Nie, Hanxiang
    Tang, Zheng
    Chen, Guozhong
    Huang, Jizhen
    AGING-US, 2023, 15 (19): : 10524 - 10539
  • [2] Elastase modifies bleomycin-induced pulmonary fibrosis in mice
    Silva Neto Trajano, Larissa Alexsandra
    Lima Trajano, Eduardo Tavares
    Lanzetti, Manuella
    Amorim Mendonca, Morena Scopel
    Guilherme, Rafael Freitas
    Figueiredo, Rodrigo Tinoco
    Benjamim, Claudia Farias
    Valenca, Samuel Santos
    Alto Costa, Andrea Monte
    Porto, Luis Cristovao
    ACTA HISTOCHEMICA, 2016, 118 (03) : 203 - 212
  • [3] Induced pluripotent stem cells reduce neutrophil chemotaxis via activating GRK2 in endotoxin-induced acute lung injury
    Su, Vincent Yi-Fong
    Chiou, Shih-Hwa
    Lin, Chi-Shiuan
    Chen, Wei-Chih
    Yu, Wen-Kuang
    Chen, Yen-Wen
    Chen, Cheng-Yu
    Yang, Kuang-Yao
    RESPIROLOGY, 2017, 22 (06) : 1156 - 1164
  • [4] Metformin Reduces Bleomycin-induced Pulmonary Fibrosis in Mice
    Choi, Sun Mi
    Jang, An-Hee
    Kim, Hyojin
    Lee, Kyu Hwa
    Kim, Young Whan
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2016, 31 (09) : 1419 - 1425
  • [5] Mefunidone Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
    Han, Yuanyuan
    Jiang, Mao
    He, Rongling
    Lv, Xin
    Liao, Xiaohua
    He, Yijun
    Zhang, Fan
    Long, Lingzhi
    Jiang, Guoliang
    Peng, Zhangzhe
    Tao, Lijian
    Hu, Gaoyun
    Meng, Jie
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [6] Ibrutinib Exacerbates Bleomycin-Induced Pulmonary Fibrosis via Promoting Inflammation
    Gu, Yangyang
    Huang, Bo
    Yang, Yanfei
    Qi, Mengdie
    Lu, Guohua
    Xia, Dajing
    Li, Hequan
    INFLAMMATION, 2018, 41 (03) : 904 - 913
  • [7] Adenophorae Radix Reduces Fibrosis in a Bleomycin-Induced Pulmonary Fibrosis Mouse Model
    Kim, Eui-Joong
    Park, Jiwon
    Yu, Chang-Hwan
    Park, Jae-Woo
    Kim, Kwan-Il
    Jung, Hee-Jae
    Kim, Jang-Hoon
    Bu, Youngmin
    Lee, Beom-Joon
    NATURAL PRODUCT COMMUNICATIONS, 2024, 19 (01)
  • [8] Nintedanib Regulates GRK2 and CXCR2 to Reduce Neutrophil Recruitment in Endotoxin-Induced Lung Injury
    Su, Vincent Yi-Fong
    Chen, Wei-Chih
    Yu, Wen-Kuang
    Wu, Huai-Hsuan
    Chen, Hao
    Yang, Kuang-Yao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
  • [9] Role of thioredoxin nitration in bleomycin-induced pulmonary fibrosis in rats
    Wang, Lei
    Song, Yimin
    Li, Xiankui
    Guo, Haizhou
    Zhang, Guojun
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2016, 94 (01) : 59 - 64
  • [10] Glaucocalyxin A improves survival in bleomycin-induced pulmonary fibrosis in mice
    Yang, Fei
    Cao, Yiren
    Zhang, Jian
    You, Tao
    Zhu, Li
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 482 (01) : 147 - 153